First MRNA COVID Vaccine Given Nod For Phase 2/3 Trials In India
[email protected]25 Oct, 2021News
The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India's first Covid-19 mRNA vaccine. Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation's first mRNA-based Covid-19 vaccine. It is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot.
Related Bookmarks
- India�s First MRNA Covid-19 Vaccine Gets Approval For Phase II And III Trials By Centre
- DCGI Finds First MRNA Vaccine Safe, Gives Nods For Phase 2/3 Trials
- Healthy Floor Makes A Healthy Home
- agence de voyage qui s'occupe des visas
- Why Is Hulu Not Loading on Chrome?
- Best Gutter Cleaning Services to Contact in Esher
- How to Add Social Media Feed to Website
- 4 Things Every Hotel Needs To Consider Before Finalizing With A Hotel Supplier
- UPS Maintenance Tips You Must Know
- How to Change the Email Address on Instagram?
Recent Profiles
Ae888
Sphereguide
Kebabs And More
Quest Drilling Services Ltd
Edgar Henry
922bet
Richard Horvat
Wcart
Primekart
Services Fiptro